These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10236647)

  • 1. Development of a course of study in FDA drug regulatory procedures.
    Jacobs RW; King JC
    Am J Pharm Educ; 1977 May; 41(2):185-88. PubMed ID: 10236647
    [No Abstract]   [Full Text] [Related]  

  • 2. The case for boards in clinical pharmacology.
    DiPalma JR
    JAMA; 1980 May; 243(19):1918-20. PubMed ID: 7365973
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA and the practice of pharmacy: prescription drug regulation before the Durham-Humphrey Amendment of 1951.
    Swann JP
    Pharm Hist; 1994; 36(2):55-70. PubMed ID: 11613485
    [No Abstract]   [Full Text] [Related]  

  • 4. Opioid peptides as drug products: FDA regulatory requirements.
    Hoiberg CP; Rapaka RS
    NIDA Res Monogr; 1986; 70():385-404. PubMed ID: 3093882
    [No Abstract]   [Full Text] [Related]  

  • 5. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manpower development through pharmacy administration graduate programs.
    Evanson RV; Norwood GJ; Speranza KA; Wertheimer AI
    Am J Pharm Educ; 1975 Aug; 39(3):330-3. PubMed ID: 10237136
    [No Abstract]   [Full Text] [Related]  

  • 7. The US Food and Drug Administration and probiotics: regulatory categorization.
    Degnan FH
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S133-6; discussion S144-51. PubMed ID: 18181719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA regulatory compliance reconsidered.
    Tobias C
    Cornell Law Rev; 2008 Jul; 93(5):1003-38. PubMed ID: 18618969
    [No Abstract]   [Full Text] [Related]  

  • 9. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Dec; 64(232):67720-63. PubMed ID: 11010665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Court files order in pharmacies' case against FDA.
    J Am Vet Med Assoc; 2006 Oct; 229(8):1228. PubMed ID: 17066572
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics: regulatory aspects. Point of view of FDA.
    Teske RH; Newkirk DR
    Vet Hum Toxicol; 1990 Jun; 32(3):261-2. PubMed ID: 2353440
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimizing the FDA inspector's training--the URI program.
    Youngken HW
    Bull Parenter Drug Assoc; 1971; 25(4):185-92. PubMed ID: 5171321
    [No Abstract]   [Full Text] [Related]  

  • 13. New prescription for drug regulation.
    Pines WL
    FDA Consum; 1978 Jun; 12(5):7-10. PubMed ID: 10308117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical education in the United States of America--professional and graduate.
    Swintosky JV
    Am J Pharm Sci Support Public Health; 1974; 146(3):75-85. PubMed ID: 4853597
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA milestones.
    FDA Consum; 2006; 40(1):36-8. PubMed ID: 16528826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critics fear the FDA is going too far in cutting industry's regulatory load.
    Demkovich LE
    Natl J (Wash); 1982 Jul; 14(29):1249-52. PubMed ID: 10255878
    [No Abstract]   [Full Text] [Related]  

  • 17. Pediatric drug development in anesthesiology: an FDA perspective.
    Schultheis LW; Mathis LL; Roca RA; Simone AF; Hertz SH; Rappaport BA
    Anesth Analg; 2006 Jul; 103(1):49-51. PubMed ID: 16790624
    [No Abstract]   [Full Text] [Related]  

  • 18. A visit from the FDA.
    Brett J
    J Am Vet Med Assoc; 1994 May; 204(9):1319-20. PubMed ID: 8050959
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA acts on estrogen, progestin labeling.
    FDA Consum; 1977 Nov; 11(9):3. PubMed ID: 10305006
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA perspectives on supplement use by patients on antithrombotic therapy: dietary supplement regulatory overview.
    Woo JJ
    Thromb Res; 2005; 117(1-2):193-6; discussion 201-7. PubMed ID: 16253311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.